The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 10,575 | 529,551 | SH | SOLE | 529,551 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 17,869 | 1,130,919 | SH | SOLE | 1,130,919 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339955 | 5,530 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
Arbutus Biopharma Corporation | COM | 03879J100 | 19,358 | 2,651,825 | SH | SOLE | 2,651,825 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 3,611 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 17,989 | 270,424 | SH | SOLE | 270,424 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 33,639 | 851,200 | SH | SOLE | 851,200 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 27,154 | 2,023,369 | SH | SOLE | 2,023,369 | 0 | 0 | ||
Eidos Therapeutics, Inc. | COM | 28249H104 | 4,985 | 245,082 | SH | SOLE | 245,082 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 29,151 | 1,231,543 | SH | SOLE | 1,231,543 | 0 | 0 | ||
Insmed Incorporated | COM | 457669307 | 42,584 | 1,800,587 | SH | SOLE | 1,800,587 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | 1,639 | 94,477 | SH | SOLE | 94,477 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 28,090 | 565,755 | SH | SOLE | 565,755 | 0 | 0 | ||
OptiNose, Inc. | COM | 68404V100 | 25,981 | 928,545 | SH | SOLE | 928,545 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 22,567 | 721,903 | SH | SOLE | 721,903 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 2,243 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 403 | 10,650 | SH | SOLE | 10,650 | 0 | 0 |